<li>Miguel Moutinho, Shweta S. Puntambekar, Andy P. Tsai, Israel Coronel, Peter B. Lin, Brad T. Casali, Pablo Martinez, Adrian L. Oblak, Cristian A. Lasagna-Reeves, Bruce T. Lamb, Gary E. Landreth. <strong>The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer’s disease</strong>. <em>Science Translational Medicine</em>, 2022; 14 (637) DOI: <a href="http://dx.doi.org/10.1126/scitranslmed.abl7634" rel="nofollow" target="_blank">10.1126/scitranslmed.abl7634</a>
</li>